Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-3.93	40.92	42.59
Graham Fair Price	12.24	10.17	9.06
PEG	-53.28	0.62	1.32
Price/Book	4.09	1.35	1.29
Price/Cash Flow	187.26	67.55	23.52
Prices/Earnings	-16.94	13.70	16.49
Price/Sales	9.90	10.66	9.70
Price/FCF	187.26	67.55	23.52
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.59	0.39	0.53
Operating Margin	14.25	0.31	0.27
ROA	26.09	0.01	< 0.005
ROE	0.02	0.02	25.32
ROIC	0.01	0.02	13.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.04	-97.40
Dividends QOQ	< 0.005	< 0.005	-35.54
EBIT QOQ	0.17	0.08	-51.39
EPS QOQ	0.13	0.22	77.78
FCF QOQ	1.61	-0.64	-60.37
Revenue QOQ	0.03	-0.05	51.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.69	20.96	-15.09
Days Sales Outstanding (DSO)	35.39	32.97	-6.86
Inventory Turnover	3.65	4.29	17.78
Debt/Capitalization	0.51	0.51	-0.06
Quick Ratio	0.26	0.34	30.57
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.65	13.68	0.26
Cash	0.13	0.06	-49.27
Capex	-0.30	-0.28	5.60
Free Cash Flow	0.75	0.27	-63.67
Revenue	1.82	1.73	-5.03
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.35	0.50	43.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.16	17.97	-6.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating